- Helps lower blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
- Promotes weight loss or weight maintenance due to increased glucose excretion.
- Improves glycemic control when used alongside diet and exercise.
- May reduce the risk of kidney disease progression in diabetic patients.
- Convenient once-daily dosing enhances patient adherence to treatment.
- Can be used in combination with other antidiabetic medications for improved efficacy.
Empaglyde L 10 Tablet - Strip of 10
Compositions : Empagliflozin 10mg + Linagliptin 5mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Mankind Pharma Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Empaglyde L 10 Tablet is a pharmaceutical product designed to manage blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication combines two active ingredients: empagliflozin and linagliptin, which work synergistically to enhance glycemic control. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Linagliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the levels of incretin hormones, which help regulate insulin secretion and lower blood sugar levels post-meal. The primary therapeutic purpose of Empaglyde L 10 Tablet is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone do not provide adequate control. This combination therapy not only aids in managing blood glucose levels but also offers potential cardiovascular benefits, making it a valuable option for patients with concurrent cardiovascular risk factors. The formulation is available in tablet form, allowing for convenient oral administration. Patients are advised to use Empaglyde L 10 Tablet as part of a comprehensive diabetes management plan that includes dietary modifications and physical activity. Regular monitoring of blood glucose levels is essential to assess the effectiveness of the treatment and make necessary adjustments. Overall, Empaglyde L 10 Tablet represents an important advancement in diabetes care, providing a dual mechanism of action that addresses both insulin secretion and glucose reabsorption, thereby supporting better overall metabolic health.
Product Details
- Empagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased urinary glucose excretion leads to lower blood sugar levels.
- Linagliptin enhances incretin hormone levels, stimulating insulin secretion post-meal.
- Reduces glucagon secretion, which decreases hepatic glucose production.
- The combination of both mechanisms provides comprehensive glycemic control.
- Take one Empaglyde L 10 Tablet orally once daily, preferably at the same time each day.
- Swallow the tablet whole with water; do not crush or chew.
- Dosage may be adjusted based on individual blood sugar levels and physician recommendations.
- Monitor blood glucose levels regularly to assess treatment effectiveness.
- Continue following dietary and exercise recommendations while on this medication.
- If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Stay hydrated by drinking plenty of water throughout the day.
- Monitor blood sugar levels regularly to understand how food and activity affect your diabetes management.
- Avoid excessive alcohol consumption as it can affect blood sugar levels.
Safety Advice
Side Effects
- Common side effects include:
- Urinary tract infections
- Genital fungal infections
- Nausea
- Diarrhea
- Serious side effects may include:
- Ketoacidosis (symptoms include nausea, vomiting, abdominal pain)
- Severe allergic reactions (rash, itching, swelling)
- Kidney problems (changes in urination)
- If you experience symptoms of ketoacidosis or severe allergic reactions, seek medical attention immediately.
Precautions and Warnings
- Avoid use if you have a history of severe allergic reactions to empagliflozin or linagliptin.
- Use with caution in patients with kidney or liver impairment; dosage adjustments may be necessary.
- Consult your doctor before using if you are pregnant or breastfeeding.
- Avoid excessive alcohol consumption as it can increase the risk of dehydration and affect blood sugar levels.
- Monitor blood sugar levels closely to prevent hypoglycemia when used with other antidiabetic medications.
FAQs
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Can I take Empaglyde L 10 Tablet if I am pregnant?
Empaglyde L 10 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternatives.
3. Are there any food interactions with Empaglyde L 10 Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial for effective diabetes management.
4. What are the common side effects of Empaglyde L 10 Tablet?
Common side effects may include urinary tract infections, genital infections, and dehydration.
5. Is it safe to drive while taking Empaglyde L 10 Tablet?
Generally, it is safe to drive; however, monitor your blood sugar levels to avoid hypoglycemia.
6. How should I store Empaglyde L 10 Tablet?
Store at room temperature away from moisture and heat. Keep out of reach of children.
Instructions
No content available for this section.
More Information
| SKU | 600469 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Mankind Pharma Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Empaglyde L 10 Tablet is a pharmaceutical product designed to manage blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication combines two active ingredients: empagliflozin and linagliptin, which work synergistically to enhance glycemic control. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Linagliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the levels of incretin hormones, which help regulate insulin secretion and lower blood sugar levels post-meal. The primary therapeutic purpose of Empaglyde L 10 Tablet is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone do not provide adequate control. This combination therapy not only aids in managing blood glucose levels but also offers potential cardiovascular benefits, making it a valuable option for patients with concurrent cardiovascular risk factors. The formulation is available in tablet form, allowing for convenient oral administration. Patients are advised to use Empaglyde L 10 Tablet as part of a comprehensive diabetes management plan that includes dietary modifications and physical activity. Regular monitoring of blood glucose levels is essential to assess the effectiveness of the treatment and make necessary adjustments. Overall, Empaglyde L 10 Tablet represents an important advancement in diabetes care, providing a dual mechanism of action that addresses both insulin secretion and glucose reabsorption, thereby supporting better overall metabolic health.
- Helps lower blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
- Promotes weight loss or weight maintenance due to increased glucose excretion.
- Improves glycemic control when used alongside diet and exercise.
- May reduce the risk of kidney disease progression in diabetic patients.
- Convenient once-daily dosing enhances patient adherence to treatment.
- Can be used in combination with other antidiabetic medications for improved efficacy.
- Empagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased urinary glucose excretion leads to lower blood sugar levels.
- Linagliptin enhances incretin hormone levels, stimulating insulin secretion post-meal.
- Reduces glucagon secretion, which decreases hepatic glucose production.
- The combination of both mechanisms provides comprehensive glycemic control.
- Take one Empaglyde L 10 Tablet orally once daily, preferably at the same time each day.
- Swallow the tablet whole with water; do not crush or chew.
- Dosage may be adjusted based on individual blood sugar levels and physician recommendations.
- Monitor blood glucose levels regularly to assess treatment effectiveness.
- Continue following dietary and exercise recommendations while on this medication.
- If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Stay hydrated by drinking plenty of water throughout the day.
- Monitor blood sugar levels regularly to understand how food and activity affect your diabetes management.
- Avoid excessive alcohol consumption as it can affect blood sugar levels.
Side Effects
- Common side effects include:
- Urinary tract infections
- Genital fungal infections
- Nausea
- Diarrhea
- Serious side effects may include:
- Ketoacidosis (symptoms include nausea, vomiting, abdominal pain)
- Severe allergic reactions (rash, itching, swelling)
- Kidney problems (changes in urination)
- If you experience symptoms of ketoacidosis or severe allergic reactions, seek medical attention immediately.
Precautions and Warnings
- Avoid use if you have a history of severe allergic reactions to empagliflozin or linagliptin.
- Use with caution in patients with kidney or liver impairment; dosage adjustments may be necessary.
- Consult your doctor before using if you are pregnant or breastfeeding.
- Avoid excessive alcohol consumption as it can increase the risk of dehydration and affect blood sugar levels.
- Monitor blood sugar levels closely to prevent hypoglycemia when used with other antidiabetic medications.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Can I take Empaglyde L 10 Tablet if I am pregnant?
Empaglyde L 10 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternatives.
3. Are there any food interactions with Empaglyde L 10 Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial for effective diabetes management.
4. What are the common side effects of Empaglyde L 10 Tablet?
Common side effects may include urinary tract infections, genital infections, and dehydration.
5. Is it safe to drive while taking Empaglyde L 10 Tablet?
Generally, it is safe to drive; however, monitor your blood sugar levels to avoid hypoglycemia.
6. How should I store Empaglyde L 10 Tablet?
Store at room temperature away from moisture and heat. Keep out of reach of children.
No content available for this section.
| SKU | 600469 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Mankind Pharma Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account